Eastgate Biotech Corp Deferred Revenue
Eastgate Biotech Corp had Deferred Revenue of $92.52 thousand as of 2016-12-31, per its 10-K filed 2018-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2018-03-01
- 2016-12-31: Deferred Revenue, Current $92.52K.
- 2016-09-30: Deferred Revenue, Current $94.55K.
- 2016-06-30: Deferred Revenue, Current $94.17K.
- 2016-03-31: Deferred Revenue, Current $26.60K; Deferred Revenue, Current as first filed $25.50K.
| Period end | Deferred Revenue, Current | Deferred Revenue, Current as first filed |
|---|---|---|
| 2016-12-31 | $92.52K 10-K · filed 2018-03-01 | |
| 2016-09-30 | $94.55K 10-Q/A · filed 2018-03-01 | |
| 2016-06-30 | $94.17K 10-Q/A · filed 2018-03-01 | |
| 2016-03-31 | $26.60K 10-Q/A · filed 2018-03-01 | $25.50K 10-Q · filed 2017-02-27 |
| 2015-12-31 | $23.85K 10-K · filed 2018-03-01 |